Form D · Biotechnology

ALLOCURE INC

Burlington, MA · CIK 0001439955

Offering snapshot reported Dec 23, 2013 · SEC filing

Reported sold
$26.5M
Offering amount: $26.5M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 29, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$13.3M$26.5MApr 10, 2012: $16,500,005.00Apr 10, 2012Dec 23, 2013: $26,500,008.00Dec 23, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$16,500,005 → $26,500,008

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 23, 2013Amendment$26,500,008$10,000,003vs Apr 10, 20125SEC filing
Apr 10, 2012Initial$16,500,005No comparison5SEC filing
Oct 13, 2011Initial$1,501,500No comparison4SEC filing
Nov 18, 2009Initial$5,588,179No comparison4SEC filing
Jul 7, 2009Initial$400,080No comparison4SEC filing
Jul 11, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jul 11, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-176419

Source: Form D, filed Dec 23, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mette Kirstine Agger Director
Robert M Brenner Director, Executive
Scott Canute Director
Thomas Dryberg Director
Thomas Dyrberg Director
George Eldridge Executive
Lutz Giebel Director
David Guyer Director
Kevin J. Heyeck Executive
Christof Westenfelder Director, Executive
John B. Wirthlin Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
25 Corporate Drive Suite 360
Burlington, MA, 01803